Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Valvular heart disease in elderly adults

Dania Mohty, MD, PhD
Sorin Pislaru, MD, PhD
Section Editors
Catherine M Otto, MD
Kenneth E Schmader, MD
Deputy Editor
Susan B Yeon, MD, JD, FACC


The diagnosis and management of valvular heart disease in elderly adults has been affected by the dramatic increase in life expectancy that began in the last half of the 20th century. In the United States, for example, the number of persons aged 80 years or older is expected to increase from 6.9 million in 1990 to approximately 25 million by the year 2050 [1]. As a result, degenerative valve disease is likely to become an increasing problem. Furthermore, the prevalence of valvular disease is increasing with age, with more than one in eight people age 75 and older having moderate or severe valve disease [2].

Fortunately, there have been major advances in cardiac surgery, which affect the consideration of surgical treatment in elderly patients who in the past may not have been surgical candidates. Among patients who survive the surgery and perioperative period, the level of function and quality of life and, in some studies, survival are the same as in a general population of age-matched subjects [3-5]. As a result, the classic view that surgery should be considered only for elderly patients in excellent general condition is being challenged as higher success rates are obtained in patients with comorbidities that are not serious or, if uncontrolled, not overwhelming [6]. Additionally, development of percutaneous valvular interventions will further increase therapeutic choices for elderly adults. Indeed, the success of transcatheter aortic valve implantation (TAVI) has spurred active development efforts for mitral and tricuspid valve disease [7,8]. (See "Choice of therapy for symptomatic severe aortic stenosis".)

Studies have used various age criteria to identify elderly adults. Although there are no comprehensive population-based data regarding the prevalence of valvular heart disease, several studies have provided important information about the prevalence of significant valvular heart disease, stratified by age (table 1). Aortic stenosis, organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation are the most common valvular disorders in elderly adults.


Calcific or degenerative aortic valve disease is a common valvular lesion encountered among elderly patients [9-11]. In the Helsinki Aging Study, 501 randomly selected men and women aged 75 to 86 underwent imaging and Doppler echocardiography [10,11]. The prevalence of at least moderate aortic stenosis, defined as an aortic valve area (AVA) ≤1.2 cm2 and velocity ratio ≤0.35, was 5 percent; the prevalence of critical aortic stenosis (AVA ≤0.8 cm2, and velocity ratio ≤0.25) increased with age from 1 to 2 percent in persons 75 to 76 years of age up to almost 6 percent in those 86 years of age [11]. Moderate or severe aortic stenosis was more frequent in women (8.8 versus 3.6 percent in men) [10]. (See "Aortic valve area in aortic stenosis".)

Similar prevalence has been reported from referral centers and nursing home populations, with an even higher prevalence in those over 90 years of age [12,13].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Dec 2016. | This topic last updated: Thu Dec 22 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Spencer, G. US bureau of the census: Projections of the population of the united states, by age, sex and race: 1988 to 2080. Current Population 1989. p.1018.
  2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005.
  3. Olsson M, Granström L, Lindblom D, et al. Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol 1992; 20:1512.
  4. Olsson M, Janfjäll H, Orth-Gomér K, et al. Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients. Eur Heart J 1996; 17:583.
  5. Shapira OM, Kelleher RM, Zelingher J, et al. Prognosis and quality of life after valve surgery in patients older than 75 years. Chest 1997; 112:885.
  6. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98:1949.
  7. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187.
  8. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597.
  9. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231.
  10. Iivanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996; 78:97.
  11. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21:1220.
  12. Aronow WS, Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol 1991; 67:776.
  13. Tunick PA, Freedberg RS, Kronzon I. Cardiac findings in the very elderly: analysis of echocardiography in fifty-eight nonagenarians. Gerontology 1990; 36:206.
  14. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc 1987; 62:119.
  15. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920.
  16. Roberts WC, Ko JM, Moore TR, Jones WH 3rd. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006; 114:422.
  17. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630.
  18. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341:142.
  19. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57.
  20. Tsai TP, Denton TA, Chaux A, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients > or = 90 years of age. Am J Cardiol 1994; 74:960.
  21. Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients 80 years and older. Operative risks and long-term results. Circulation 1993; 88:II11.
  22. Bessou JP, Bouchart F, Angha S, et al. Aortic valvular replacement in octogenarians. Short-term and mid-term results in 140 patients. Cardiovasc Surg 1999; 7:355.
  23. Gilbert T, Orr W, Banning AP. Surgery for aortic stenosis in severely symptomatic patients older than 80 years: experience in a single UK centre. Heart 1999; 82:138.
  24. Freeman WK, Schaff HV, O'Brien PC, et al. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol 1991; 18:29.
  25. Asimakopoulos G, Edwards MB, Taylor KM. Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation 1997; 96:3403.
  26. Akins CW, Daggett WM, Vlahakes GJ, et al. Cardiac operations in patients 80 years old and older. Ann Thorac Surg 1997; 64:606.
  27. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747.
  28. Kvidal P, Bergström R, Malm T, Ståhle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000; 21:1099.
  29. Egbe AC, Pislaru SV, Pellikka PA, et al. Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. J Am Coll Cardiol 2015; 66:2285.
  30. Makkar RR, Fontana G, Jilaihawi H, et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med 2015; 373:2015.
  31. Yun KL, Miller DC, Moore KA, et al. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995; 60:S221.
  32. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36:1152.
  33. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003; 41:893.
  34. Cohn LH. Use of heart valves in older patients. Circulation 2005; 111:2152.
  35. Isaacs AJ, Shuhaiber J, Salemi A, et al. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg 2015; 149:1262.
  36. Arom KV, Goldenberg IF, Emery RW. Long-term clinical outcome with small size Standard St Jude Medical valves implanted in the aortic position. J Heart Valve Dis 1994; 3:531.
  37. Pibarot P, Dumesnil JG, Lemieux M, et al. Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis 1998; 7:211.
  38. Franzen SF, Huljebrant IE, Konstantinov IE, et al. Aortic valve replacement for aortic stenosis in patients with small aortic root. J Heart Valve Dis 1996; 5 Suppl 3:S284.
  39. Kratz JM, Sade RM, Crawford FA Jr, et al. The risk of small St. Jude aortic valve prostheses. Ann Thorac Surg 1994; 57:1114.
  40. Adams DH, Chen RH, Kadner A, et al. Impact of small prosthetic valve size on operative mortality in elderly patients after aortic valve replacement for aortic stenosis: does gender matter? J Thorac Cardiovasc Surg 1999; 118:815.
  41. Sawant D, Singh AK, Feng WC, et al. Nineteen-millimeter aortic St. Jude Medical heart valve prosthesis: up to sixteen years' follow-up. Ann Thorac Surg 1997; 63:964.
  42. Medalion B, Lytle BW, McCarthy PM, et al. Aortic valve replacement for octogenarians: are small valves bad? Ann Thorac Surg 1998; 66:699.
  43. Barner HB, Labovitz AJ, Fiore AC. Prosthetic valves for the small aortic root. J Card Surg 1994; 9:154.
  44. Mohty D, Dumesnil JG, Echahidi N, et al. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol 2009; 53:39.
  45. Sommers KE, David TE. Aortic valve replacement with patch enlargement of the aortic annulus. Ann Thorac Surg 1997; 63:1608.
  46. David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg 1998; 116:236.
  47. David TE. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg 1998; 13:344.
  48. Pibarot P, Weissman NJ, Stewart WJ, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. J Am Coll Cardiol 2014; 64:1323.
  49. Zorn GL 3rd, Little SH, Tadros P, et al. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg 2016; 151:1014.
  50. Bernard Y, Etievent J, Mourand JL, et al. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. J Am Coll Cardiol 1992; 20:796.
  51. Soyer R, Bouchart F, Bessou JP, et al. Aortic valve replacement after aortic valvuloplasty for calcified aortic stenosis. Eur J Cardiothorac Surg 1996; 10:977.
  52. Hara H, Pedersen WR, Ladich E, et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 2007; 115:e334.
  53. Eltchaninoff H, Cribier A, Tron C, et al. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J 1995; 16:1079.
  54. Lieberman EB, Wilson JS, Harrison JK, et al. Aortic valve replacement in adults after balloon aortic valvuloplasty. Circulation 1994; 90:II205.
  55. Saia F, Marrozzini C, Ciuca C, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention 2013; 8:1388.
  56. Panchal HB, Ladia V, Desai S, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Am J Cardiol 2013; 112:850.
  57. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.
  58. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83:897.
  59. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366:1686.
  60. Vasa-Nicotera M, Sinning JM, Chin D, et al. Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012; 5:858.
  61. Aronow WS, Kronzon I. Correlation of prevalence and severity of mitral regurgitation and mitral stenosis determined by Doppler echocardiography with physical signs of mitral regurgitation and mitral stenosis in 100 patients aged 62 to 100 years with mitral anular calcium. Am J Cardiol 1987; 60:1189.
  62. Labovitz AJ, Nelson JG, Windhorst DM, et al. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography. Am J Cardiol 1985; 55:133.
  63. Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 1987; 62:22.
  64. Jebara VA, Dervanian P, Acar C, et al. Mitral valve repair using Carpentier techniques in patients more than 70 years old. Early and late results. Circulation 1992; 86:II53.
  65. Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 1991; 52:1246.
  66. Lee EM, Porter JN, Shapiro LM, Wells FC. Mitral valve surgery in the elderly. J Heart Valve Dis 1997; 6:22.
  67. Grossi E. Mitral valve repair in the elderly. Cardiol Elderly 1995; 3:269.
  68. Goldsmith I, Lip GY, Kaukuntla H, Patel RL. Hospital morbidity and mortality and changes in quality of life following mitral valve surgery in the elderly. J Heart Valve Dis 1999; 8:702.
  69. Asimakopoulos G, Edwards MB, Brannan J, Taylor KM. Survival and cause of death after mitral valve replacement in patients aged 80 years and over: collective results from the UK heart valve registry. Eur J Cardiothorac Surg 1997; 11:922.
  70. Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35:731.
  71. Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004; 110:356.
  72. Enriquez-Sarano M, Schaff HV, Frye RL. Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation 2003; 108:253.
  73. Thourani VH, Weintraub WS, Guyton RA, et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation 2003; 108:298.
  74. Grossi EA, Zakow PK, Sussman M, et al. Late results of mitral valve reconstruction in the elderly. Ann Thorac Surg 2000; 70:1224.
  75. Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 2006; 114:265.
  76. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364:1395.
  77. Iung B, Cormier B, Farah B, et al. Percutaneous mitral commissurotomy in the elderly. Eur Heart J 1995; 16:1092.
  78. Sutaria N, Elder AT, Shaw TR. Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over. Heart 2000; 83:433.
  79. Guerrero M, Dvir D, Himbert D, et al. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. JACC Cardiovasc Interv 2016; 9:1361.
  80. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43:405.
  81. Lee JW, Song JM, Park JP, et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74:375.
  82. Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5:314.
  83. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451.
  84. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Excess mortality due to coronary artery disease after valve surgery. Secular trends in valvular regurgitation and effect of internal mammary artery bypass. Circulation 1998; 98:II108.
  85. Davis EA, Gardner TJ, Gillinov AM, et al. Valvular disease in the elderly: influence on surgical results. Ann Thorac Surg 1993; 55:333.